Intuitive Surgical reported second quarter 2026 revenue of $2.89 billion, up 19% year-over-year, and non-GAAP EPS of $2.80. Results were driven by continued strength in system placements and procedure volumes, which led to higher recurring instrument and accessory sales.
Key Highlights
- Worldwide procedure volume grew approximately 16% year-over-year, supported by 15% growth in da Vinci procedures and 36% growth in Ion procedures.
- The company placed 468 da Vinci surgical systems, an 18% increase from the 395 systems placed in the same quarter of the prior year.
- For the full year 2026, the company expects worldwide da Vinci procedure growth of approximately 13.5% to 15.5%.